NCT04495257 2025-10-30A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)Yale UniversityPhase 1 Active not recruiting26 enrolled